Home › Funds › Atika Capital Management LLC › UTHR
Atika Capital Management LLC position in UTHR
UNITED THERAPEUTICS CORP DEL · Health Care
Atika Capital Management LLC reported holding 12,000 shares of UTHR (UNITED THERAPEUTICS CORP DEL) in its Q3 2026 13F filing — a position valued at US$6.5M, representing 0.61% of its reported portfolio and ranking #43 among its reported holdings. Atika Capital Management LLC has disclosed UTHR holdings in 5 of the last 10 reported quarters, going back to Q2 2024.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Atika Capital Management LLC's UTHR position evolved
Atika Capital Management LLC first disclosed a stake in UTHR in Q2 2024 at 29,000 shares (US$9.2M). The position peaked in Q4 2024 at 31,000 shares, worth US$10.9M. Across 5 filings, Atika Capital Management LLC increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 12,000 shares valued at US$6.5M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2024 | 29.00K | $9.24M | New |
| Q3 2024 | 27.50K | $9.85M | Reduce |
| Q4 2024 | 31.00K | $10.94M | Add |
| Q1 2026 | 12.35K | $7.32M | New |
| Q3 2026 | 12.00K | $6.50M | New |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About UTHR and 13F data
UTHR (UNITED THERAPEUTICS CORP DEL) is a Health Care company. 39 other funds we track also report a position in UTHR — the largest reported positions include Avoro Capital Advisors LLC (US$1.51B), Renaissance Technologies (US$908.2M), ASSETMARK, INC (US$325.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding UTHR
- Avoro Capital Advisors LLC 2.78M sh · $1.51B · Q2 2026
- Renaissance Technologies 1.68M sh · $908.15M · Q3 2026
- ASSETMARK, INC 600.17K sh · $325.23M · Q3 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 457.00K sh · $247.62M · Q2 2026
- Vestal Point Capital, LP 435.00K sh · $235.70M · Q2 2026
- Eversept Partners, LP 287.67K sh · $155.87M · Q2 2026
More on Atika Capital Management LLC
FAQ
How long has Atika Capital Management LLC held UTHR?
Atika Capital Management LLC has disclosed UTHR holdings in 5 of the last 10 reported quarters, going back to Q2 2024.
What is Atika Capital Management LLC's current position in UTHR?
As of Q3 2026, Atika Capital Management LLC holds 12.00K shares of UTHR (UNITED THERAPEUTICS CORP DEL), valued at $6.50M, representing 0.61% of its reported portfolio and ranking #43.
Has Atika Capital Management LLC been buying or selling UTHR?
In the latest 13F filing (Q3 2026), Atika Capital Management LLC newly opened its position in UTHR. The position peaked in Q4 2024 at 31.00K shares.
Which other funds hold UTHR?
Other major institutional holders of UTHR include Avoro Capital Advisors LLC, Renaissance Technologies, ASSETMARK, INC, among 39 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.